Fortrea Holdings Inc. (FTRE) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
Total Assets Chart for Fortrea Holdings Inc.
Fortrea Holdings Inc. (FTRE) total assets for FY2025 were USD 2.7B, a -24.1% change from FY2024. Fortrea Holdings Inc.'s total assets grew from USD 4.4B in 2021 to USD 2.7B in 2025 (-37.8% over 4 years).
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $2.25B
- Implied Share Price
- $23.63
- Enterprise Value
- $2.03B
- Revenue (TTM)
- $2.68B
- EBITDA
- $98.30M
- Profit Margin
- -3.18%
- Trailing P/E
- —
- Forward P/E
- 6.12
- Price/Book (MRQ)
- 1.48
- Price/Sales (TTM)
- 0.84
- EV/EBITDA
- 92.35
- EV/Revenue
- 0.74
- Dividend Yield
- —
- Book Value
- $5.51
- Free Cash Flow (FY2025)
- $88.30M
- Free Cash Flow Yield
- 3.93%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.